The thyroid gland, a small butterfly-shaped organ at the base of the neck, serves as the body’s metabolic thermostat. It produces hormones that regulate how every cell uses energy — influencing heart rate, body temperature, weight, mood, cognitive function, and countless other processes. When the thyroid fails to produce enough hormone, the result is hypothyroidism — a condition where the body’s metabolism slows, affecting virtually every organ system.

Hypothyroidism is remarkably common, affecting approximately 5% of adults in developed countries, with women five to eight times more likely to be affected than men. The prevalence increases significantly with age — by age 60, up to 10% of women have some degree of thyroid underactivity. Yet despite its prevalence, hypothyroidism remains dramatically underdiagnosed. Studies suggest that up to 60% of people with thyroid disease are unaware of their condition, suffering for years with symptoms they attribute to aging, stress, depression, or simply “slowing down.”

The challenge with hypothyroidism is that it develops insidiously. The thyroid doesn’t fail suddenly — it gradually loses function over months or years. Symptoms appear slowly and nonspecifically: fatigue that builds imperceptibly, weight gain that seems resistant to diet and exercise, feeling cold when others are comfortable, constipation, dry skin, thinning hair, difficulty concentrating, low mood. Each symptom alone might be dismissed, but together they paint a picture of metabolic slowdown that significantly impacts quality of life.

What makes hypothyroidism particularly important from a prevention perspective is its profound treatability. Unlike many chronic conditions that require complex management, hypothyroidism is treated with a single daily pill — synthetic thyroid hormone that replaces what the body no longer produces. With proper treatment, thyroid hormone levels normalize, symptoms resolve, and patients return to full health. The key is diagnosis, and diagnosis requires testing.

This is where blood testing becomes transformative. A simple TSH (thyroid-stimulating hormone) test can detect hypothyroidism — often before symptoms become severe. When the thyroid underperforms, the pituitary gland releases more TSH in an attempt to stimulate hormone production; elevated TSH is the earliest and most sensitive marker of thyroid failure. Routine TSH screening, particularly in high-risk groups, identifies hypothyroidism early, enabling treatment that prevents years of unnecessary symptoms and the complications that untreated disease can cause.

This guide provides a comprehensive overview of hypothyroidism — from the basic physiology of thyroid function to the causes of thyroid failure, from the diverse symptoms of underactive thyroid to the testing that detects it, and from treatment options to the importance of monitoring and follow-up. Understanding hypothyroidism empowers you to recognize its subtle signs and seek the testing that leads to diagnosis and treatment.

Quick Summary:

• Hypothyroidism affects ~5% of adults — with up to 60% undiagnosed
• Women are 5-8x more likely to develop hypothyroidism than men
• Hashimoto’s thyroiditis (autoimmune) causes 90% of cases in iodine-sufficient areas
• Symptoms develop gradually: Fatigue, weight gain, cold intolerance, constipation, dry skin, depression, cognitive slowing
• TSH is the primary screening test — elevated TSH indicates thyroid underfunction
• Free T4 confirms diagnosis — low Free T4 with high TSH = overt hypothyroidism
• Subclinical hypothyroidism: Elevated TSH with normal Free T4 — may progress to overt disease
• Thyroid antibodies (TPO, thyroglobulin) identify autoimmune cause
• Treatment is simple: Daily levothyroxine (synthetic T4) replaces missing hormone
• Response to treatment: Symptoms improve within weeks; full effect in 4-6 weeks
• Lifelong treatment required in most cases — but highly effective with proper monitoring
• Untreated complications: Cardiovascular disease, dyslipidemia, infertility, myxedema coma (rare, severe)
• Screening recommended for: Women over 35, pregnant women, those with risk factors or suggestive symptoms

---

Understanding Thyroid Function

The Thyroid Gland

The thyroid is a butterfly-shaped endocrine gland located at the front of the neck, just below the Adam’s apple and wrapped around the trachea (windpipe). Despite weighing only about 20 grams (less than an ounce), this small gland has enormous influence over bodily functions. The thyroid consists of two lobes connected by a narrow bridge called the isthmus.

The thyroid’s primary function is producing thyroid hormones — chemical messengers that regulate metabolism throughout the body. Metabolism encompasses all the chemical processes that convert food into energy, build and repair tissues, and maintain bodily functions. Thyroid hormones essentially set the pace at which these processes occur.

Thyroid Hormones: T4 and T3

The thyroid produces two main hormones:

Thyroxine (T4): The predominant hormone, accounting for about 80-90% of thyroid output. T4 contains four iodine atoms (hence “T4”). It functions primarily as a prohormone — a reservoir that is converted to the more active T3 in peripheral tissues. T4 has a relatively long half-life of about 7 days, providing stable hormone levels.

Triiodothyronine (T3): The active hormone that exerts most of the biological effects. T3 contains three iodine atoms. Only about 20% of T3 comes directly from the thyroid; the majority is produced by conversion from T4 in the liver, kidneys, and other tissues. T3 has a shorter half-life of about 1 day.

In the blood, most T4 and T3 circulates bound to carrier proteins; only a small fraction (about 0.03% of T4 and 0.3% of T3) circulates “free” and available to enter cells and exert biological effects. Laboratory tests measuring “Free T4” and “Free T3” assess this active fraction.

The Hypothalamic-Pituitary-Thyroid Axis

Thyroid function is controlled by a sophisticated feedback system involving the hypothalamus and pituitary gland:

1. Hypothalamus releases TRH: When thyroid hormone levels are low, the hypothalamus (a region at the base of the brain) releases thyrotropin-releasing hormone (TRH).
2. Pituitary releases TSH: TRH stimulates the pituitary gland to release thyroid-stimulating hormone (TSH, also called thyrotropin).
3. Thyroid produces T4 and T3: TSH stimulates the thyroid gland to produce and release T4 and T3.
4. Negative feedback: Rising levels of T4 and T3 signal the hypothalamus and pituitary to reduce TRH and TSH release, completing the feedback loop.

This feedback system normally maintains thyroid hormone levels within a narrow range. When the thyroid fails (primary hypothyroidism), hormone production drops, causing TSH to rise as the pituitary attempts to stimulate the failing gland. This elevated TSH is the hallmark of primary hypothyroidism and the basis for screening.

What Thyroid Hormones Do

Thyroid hormones affect virtually every cell in the body:

• Metabolism: Regulate basal metabolic rate — how quickly the body uses energy at rest
• Heart: Influence heart rate and contractility
• Body temperature: Affect heat production and temperature regulation
• Gastrointestinal function: Influence gut motility and digestion
• Nervous system: Affect cognitive function, mood, and reflexes
• Musculoskeletal: Influence muscle strength and bone turnover
• Skin and hair: Affect skin hydration and hair growth
• Reproductive system: Influence menstrual cycles and fertility
• Lipid metabolism: Affect cholesterol levels
• Development: Critical for fetal brain development and childhood growth

When thyroid hormone is deficient, all these processes slow — explaining the diverse and systemic symptoms of hypothyroidism.

---

Causes of Hypothyroidism

Hypothyroidism results from any process that reduces thyroid hormone production. Understanding the cause helps predict disease course and guides management.

Hashimoto’s Thyroiditis (Autoimmune Thyroiditis)

Hashimoto’s thyroiditis is by far the most common cause of hypothyroidism in areas with adequate iodine intake, accounting for approximately 90% of cases. Named after the Japanese physician Hakaru Hashimoto who first described it in 1912, this condition is an autoimmune disease in which the immune system attacks the thyroid gland.

In Hashimoto’s, the immune system produces antibodies against thyroid proteins — primarily thyroid peroxidase (TPO), an enzyme essential for thyroid hormone synthesis, and thyroglobulin, a protein that serves as the scaffold for hormone production. These antibodies, along with immune cells (lymphocytes) that infiltrate the thyroid, gradually destroy thyroid tissue. The destruction is usually slow, occurring over years or decades.

The natural history of Hashimoto’s thyroiditis follows a typical pattern:

1. Euthyroid phase: Antibodies are present, but the thyroid maintains normal function. TSH and Free T4 are normal. This phase may last years.
2. Subclinical hypothyroidism: Thyroid function begins to decline. The remaining thyroid tissue works harder to compensate, reflected in rising TSH, but manages to maintain normal Free T4 levels.
3. Overt hypothyroidism: Eventually, compensation fails. TSH is elevated and Free T4 falls below normal. Symptoms become more apparent.
4. Potential goiter phase: Some patients develop thyroid enlargement (goiter) as the gland attempts to compensate; others have normal-sized or small thyroids.

Not everyone with Hashimoto’s progresses through all stages — some stabilize in subclinical hypothyroidism, some progress rapidly, and the timeline varies greatly between individuals.

Risk factors for Hashimoto’s include:

• Female sex: Women are 7-10 times more likely to develop Hashimoto’s than men. The reasons likely involve hormonal and genetic factors.
• Family history: Thyroid disease and autoimmune conditions cluster in families. Having a first-degree relative with Hashimoto’s or Graves’ disease increases risk.
• Personal history of autoimmune disease: Hashimoto’s often occurs alongside other autoimmune conditions — type 1 diabetes, celiac disease, rheumatoid arthritis, vitiligo, pernicious anemia, Addison’s disease, lupus. This clustering suggests shared genetic susceptibility.
• Age: Risk increases with age, particularly after 30-40, though Hashimoto’s can occur at any age including childhood.
• Genetics: Certain HLA (human leukocyte antigen) types increase susceptibility. Multiple genes contribute to autoimmune thyroid disease risk.
• Iodine intake: Paradoxically, both iodine deficiency and excess iodine can contribute to thyroid dysfunction. Excessive iodine intake may trigger autoimmunity in genetically susceptible individuals.
• Environmental factors: Smoking (increases risk of autoimmune thyroid disease), certain medications, viral infections, and other environmental triggers have been implicated but not definitively proven.

The presence of thyroid antibodies (TPO antibodies, thyroglobulin antibodies) confirms the autoimmune nature of the disease. Importantly, the presence of antibodies in patients with subclinical hypothyroidism predicts progression — those with elevated antibodies are more likely to develop overt hypothyroidism over time and may benefit from earlier treatment or closer monitoring.

Iatrogenic Causes (Medical Treatment-Related)

Medical treatments are the second most common cause of hypothyroidism in developed countries:

Thyroid surgery (thyroidectomy): Surgical removal of part or all of the thyroid gland is performed for thyroid cancer, large goiters causing compressive symptoms, nodules suspicious for malignancy, or hyperthyroidism refractory to other treatments.

• Total thyroidectomy: Removal of the entire gland causes permanent hypothyroidism requiring lifelong replacement therapy.
• Hemithyroidectomy/lobectomy: Removal of one lobe may or may not result in hypothyroidism, depending on the function of the remaining lobe. Many patients maintain normal function; others develop hypothyroidism weeks to years later.

Radioactive iodine (RAI) therapy: Radioactive iodine-131 is used to treat hyperthyroidism (Graves’ disease, toxic nodular goiter) and thyroid cancer. The radiation destroys thyroid tissue. Most patients treated with RAI become hypothyroid — this is often the intended outcome in hyperthyroidism treatment. Hypothyroidism may develop weeks to months after treatment, or sometimes years later.

External beam radiation: Radiation therapy to the head and neck for cancers (lymphoma, head and neck cancers, breast cancer with supraclavicular field) can damage the thyroid gland. Hypothyroidism may develop years or even decades after radiation exposure, making long-term thyroid monitoring essential in cancer survivors.

Medications: Several drugs can cause or contribute to hypothyroidism:

• Lithium: Used for bipolar disorder, lithium concentrates in the thyroid and inhibits hormone release. Up to 20% of patients on long-term lithium develop hypothyroidism.
• Amiodarone: This antiarrhythmic drug contains large amounts of iodine and can cause either hypothyroidism (more common in iodine-sufficient areas) or hyperthyroidism. Thyroid function must be monitored in all patients on amiodarone.
• Immune checkpoint inhibitors: Cancer immunotherapy drugs (pembrolizumab, nivolumab, ipilimumab) can trigger autoimmune thyroiditis, causing either transient thyrotoxicosis followed by hypothyroidism, or primary hypothyroidism.
• Interferon-alpha and interleukin-2: Can trigger autoimmune thyroiditis.
• Tyrosine kinase inhibitors: Various mechanisms of thyroid dysfunction.
• High-dose iodine: Contrast agents, amiodarone, kelp supplements — can cause temporary hypothyroidism in susceptible individuals (Wolff-Chaikoff effect).

Iodine Deficiency

Iodine is essential for thyroid hormone synthesis — T4 and T3 literally incorporate iodine atoms. In areas with severe iodine deficiency (historically common in mountainous and inland regions far from the sea), hypothyroidism and goiter (thyroid enlargement) were endemic. Iodine fortification of salt has largely eliminated this problem in developed countries, but iodine deficiency remains the leading cause of preventable hypothyroidism globally, affecting approximately 2 billion people worldwide.

Other Causes

Subacute thyroiditis: Viral or post-viral inflammation of the thyroid can cause a transient hypothyroid phase as the inflamed gland releases stored hormone (causing initial hyperthyroidism) and then becomes depleted. Most patients recover normal function, but some develop permanent hypothyroidism.

Postpartum thyroiditis: An autoimmune thyroid inflammation occurring in 5-10% of women within the first year after delivery. It typically causes a transient hyperthyroid phase followed by hypothyroidism. Most women recover, but up to 25% develop permanent hypothyroidism.

Central hypothyroidism: Rare forms result from pituitary or hypothalamic dysfunction rather than thyroid gland failure. Causes include pituitary tumors, pituitary surgery, head trauma, and infiltrative diseases. TSH may be low or inappropriately normal despite low thyroid hormone levels.

Congenital hypothyroidism: Present from birth due to thyroid agenesis (absent thyroid), dysgenesis (abnormal development), or inborn errors of hormone synthesis. Detected by newborn screening; requires immediate treatment to prevent intellectual disability.

---

Symptoms of Hypothyroidism

Hypothyroidism affects virtually every organ system, producing a constellation of symptoms that reflect generalized metabolic slowing. Symptoms typically develop gradually over months to years, which is why they often go unrecognized.

Classic Symptoms

System	Symptoms
Energy/General	Fatigue, lethargy, weakness, decreased stamina
Metabolic	Weight gain (usually modest), cold intolerance, feeling cold when others are comfortable
Skin/Hair/Nails	Dry skin, coarse skin, hair loss/thinning, brittle nails, puffy face
Gastrointestinal	Constipation, decreased appetite
Cardiovascular	Slow heart rate (bradycardia), elevated cholesterol
Neurological	Mental slowing, poor concentration, memory problems, depression
Musculoskeletal	Muscle aches, joint pain, stiffness, carpal tunnel syndrome
Reproductive	Menstrual irregularities (heavy periods), infertility, decreased libido

Understanding the Symptoms

Fatigue: Perhaps the most common and impactful symptom. Patients describe profound tiredness that isn’t relieved by rest, feeling “drained,” or lacking the energy for normal activities. This reflects reduced cellular energy production throughout the body.

Weight gain: Usually modest (5-10 pounds) and primarily due to fluid retention and decreased metabolic rate rather than fat accumulation. Severe obesity is rarely caused by hypothyroidism alone, though thyroid dysfunction can make weight management more difficult.

Cold intolerance: Reduced heat generation makes patients feel cold when others are comfortable. They may need extra layers, keep the thermostat higher, or have cold hands and feet.

Cognitive symptoms: Often described as “brain fog” — difficulty concentrating, slower thinking, forgetfulness, reduced mental sharpness. These symptoms can be mistaken for aging, depression, or early dementia.

Depression and mood changes: Hypothyroidism frequently causes depressive symptoms. Some patients diagnosed with depression actually have underlying hypothyroidism; treating the thyroid may improve or resolve the depression.

Skin and hair changes: Reduced cellular turnover and decreased sweating lead to dry, coarse skin. Hair becomes brittle and may fall out. The outer third of the eyebrows may thin (a classic sign). Nails become brittle and slow-growing.

Constipation: Slowed gut motility is common, causing constipation that may not respond well to usual treatments until thyroid function is corrected.

Symptoms in Special Populations

Elderly patients: Symptoms may be subtle or attributed to aging. Depression, cognitive decline, constipation, and fatigue in older adults warrant thyroid testing. Elderly patients may have fewer classic symptoms.

Children and adolescents: May present with growth delay, delayed puberty, poor school performance, and fatigue. Congenital hypothyroidism, if untreated, causes severe intellectual disability.

Pregnant women: Hypothyroidism during pregnancy risks miscarriage, preeclampsia, placental abruption, preterm delivery, and impaired fetal neurodevelopment. Screening and treatment are essential.

Subclinical Hypothyroidism

Subclinical hypothyroidism refers to mildly elevated TSH with normal Free T4 levels. Many patients with subclinical hypothyroidism have no symptoms or only subtle complaints. However, subclinical hypothyroidism may progress to overt hypothyroidism over time (especially if thyroid antibodies are present) and has been associated with cardiovascular risk in some studies. Whether to treat subclinical hypothyroidism is a nuanced decision based on TSH level, symptoms, antibody status, and other factors.

---

Effects on Blood Work

Hypothyroidism affects multiple laboratory parameters beyond thyroid function tests.

Thyroid Function Tests

TSH (Thyroid-Stimulating Hormone): The primary screening test. In primary hypothyroidism, TSH is elevated — often the first and most sensitive abnormality. The higher the TSH, the more severe the hypothyroidism. TSH is used for both diagnosis and monitoring treatment.

Free T4 (Free Thyroxine): Measures the active, unbound fraction of T4. In overt hypothyroidism, Free T4 is low. In subclinical hypothyroidism, Free T4 remains normal despite elevated TSH.

Free T3 (Free Triiodothyronine): Usually not needed for routine diagnosis or monitoring. T3 levels may remain normal even in hypothyroidism as the body preferentially converts available T4 to T3.

Thyroid antibodies:

• TPO antibodies (anti-thyroid peroxidase): Elevated in 90-95% of Hashimoto’s patients. Presence confirms autoimmune cause and predicts progression of subclinical to overt hypothyroidism.
• Thyroglobulin antibodies: Elevated in 60-80% of Hashimoto’s patients. Less specific than TPO antibodies.

Lipid Panel

Hypothyroidism significantly affects lipid metabolism:

• Elevated total cholesterol: A classic finding
• Elevated LDL cholesterol: Thyroid hormone normally promotes LDL receptor expression; deficiency reduces LDL clearance
• Elevated triglycerides: May occur
• HDL: May be decreased or unchanged

Dyslipidemia in hypothyroidism typically improves or resolves with thyroid hormone replacement. Lipid testing in someone with unexplained hypercholesterolemia should prompt TSH measurement.

Other Laboratory Abnormalities

Complete blood count:

• Anemia — usually mild, normocytic or macrocytic
• May contribute to fatigue beyond what thyroid dysfunction alone causes

Metabolic panel:

• Hyponatremia (low sodium) — due to impaired free water excretion
• Elevated creatinine — reflects decreased renal blood flow (usually reversible)

Liver enzymes:

• Mildly elevated AST, ALT, and LDH may occur

Creatine kinase (CK):

• Often elevated due to myopathy (muscle involvement)
• Can be markedly elevated, sometimes raising concern for muscle disease

Prolactin:

• May be mildly elevated (TRH stimulates prolactin release)

Patterns That Suggest Hypothyroidism

Consider thyroid testing when blood work shows:

• Unexplained elevated LDL cholesterol
• Hypercholesterolemia resistant to treatment
• Unexplained anemia (particularly macrocytic)
• Hyponatremia without obvious cause
• Elevated CK without muscle symptoms
• Mildly elevated liver enzymes

---

Diagnosis

Who Should Be Tested?

TSH testing is recommended for:

Symptomatic individuals: Anyone with symptoms suggestive of hypothyroidism (fatigue, weight gain, cold intolerance, constipation, depression, cognitive changes, menstrual irregularities)

High-risk groups for screening:

• Women over age 35-60 (recommendations vary; some suggest all women over 35)
• Pregnant women (ideally preconception or at first prenatal visit)
• Women planning pregnancy
• Those with family history of thyroid disease
• Those with personal history of autoimmune disease
• Those with prior thyroid surgery, radiation, or radioactive iodine treatment
• Those taking medications that affect thyroid function (lithium, amiodarone)
• Those with Down syndrome or Turner syndrome (increased thyroid disease risk)
• Elderly individuals with nonspecific symptoms
• Those with unexplained hypercholesterolemia

Diagnostic Testing Strategy

Step 1 — TSH: The initial screening test. TSH is exquisitely sensitive to thyroid status; it rises in response to even minor thyroid hormone deficiency.

Step 2 — Free T4: If TSH is elevated, Free T4 is measured to confirm and classify hypothyroidism:

• High TSH + Low Free T4: Overt (clinical) hypothyroidism
• High TSH + Normal Free T4: Subclinical hypothyroidism

Step 3 — Thyroid antibodies: TPO antibodies confirm autoimmune cause (Hashimoto’s) and help predict progression in subclinical cases.

Additional testing: Thyroid ultrasound is not routinely needed for hypothyroidism diagnosis but may be performed if nodules or goiter are detected on examination.

Interpreting Results

TSH and Free T4 should be interpreted together:

TSH	Free T4	Interpretation
Elevated	Low	Overt primary hypothyroidism
Elevated	Normal	Subclinical hypothyroidism
Normal	Normal	Euthyroid (normal thyroid function)
Low	Low	Central hypothyroidism (pituitary/hypothalamic cause)

The degree of TSH elevation generally correlates with severity: mildly elevated TSH with normal Free T4 represents subclinical disease; markedly elevated TSH with low Free T4 represents more severe hypothyroidism.

---

Health Consequences of Untreated Hypothyroidism

Cardiovascular Effects

Hypothyroidism has significant cardiovascular implications:

• Dyslipidemia: Elevated LDL cholesterol accelerates atherosclerosis
• Hypertension: Particularly diastolic hypertension, due to increased vascular resistance
• Cardiac dysfunction: Reduced heart contractility and cardiac output
• Pericardial effusion: Fluid accumulation around the heart in severe cases
• Accelerated coronary artery disease: Combined effect of lipids, hypertension, and endothelial dysfunction

Treatment of hypothyroidism improves lipid profile and cardiovascular risk markers.

Reproductive Consequences

Women:

• Menstrual irregularities (typically heavy, prolonged periods)
• Anovulation and infertility
• Increased miscarriage risk
• Pregnancy complications (preeclampsia, placental abruption, preterm delivery)
• Impaired fetal neurodevelopment (particularly in first trimester when fetus depends on maternal thyroid hormone)

Men:

• Decreased libido
• Erectile dysfunction
• Abnormal sperm parameters

Ensuring normal thyroid function before and during pregnancy is essential for maternal and fetal health.

Neuropsychiatric Effects

• Depression (may be misdiagnosed as primary depression)
• Cognitive impairment (“brain fog,” slowed thinking, poor memory)
• In severe cases, psychosis (“myxedema madness”)
• Peripheral neuropathy (carpal tunnel syndrome, other nerve compression)

Myxedema and Myxedema Coma

Severe, prolonged untreated hypothyroidism can cause myxedema — characterized by generalized tissue swelling, particularly of the face and extremities, due to accumulation of mucopolysaccharides. The term is sometimes used synonymously with severe hypothyroidism.

Myxedema coma is a rare but life-threatening emergency representing the extreme end of untreated hypothyroidism. Features include:

• Altered mental status progressing to coma
• Hypothermia (very low body temperature)
• Bradycardia and hypotension
• Hypoventilation
• Hyponatremia

Myxedema coma typically occurs in elderly patients with longstanding untreated hypothyroidism, often precipitated by infection, cold exposure, or medications. It requires emergency treatment and carries significant mortality even with treatment.

---

Treatment

The treatment of hypothyroidism is straightforward and highly effective. Unlike many chronic conditions requiring complex management, hypothyroidism is treated with a single daily medication that replaces the hormone the thyroid no longer produces adequately.

Levothyroxine (Synthetic T4)

Levothyroxine is the standard treatment for hypothyroidism — a synthetic form of T4 that is chemically identical to the hormone produced by the thyroid gland. It has been used safely for over 50 years and is one of the most commonly prescribed medications worldwide. Brand names include Synthroid, Levoxyl, Tirosint, and Unithroid, among others; generic formulations are also available.

How it works: Levothyroxine replaces the T4 the thyroid no longer produces adequately. Once absorbed from the gastrointestinal tract, it enters the bloodstream and is converted to T3 (the active hormone) in peripheral tissues — liver, kidneys, muscle, brain — just as endogenous T4 would be. This physiological conversion provides the body with both T4 and T3 through a single medication, mimicking normal thyroid physiology.

Starting treatment: The appropriate starting dose depends on several factors:

• Severity of hypothyroidism: More severe disease may warrant higher starting doses
• Age: Younger patients can start at higher doses; elderly patients (especially over 65-70) should start low and increase gradually
• Cardiovascular status: Patients with heart disease should start at low doses to avoid cardiac stress from sudden metabolic changes
• Body weight: Full replacement dose is typically calculated based on body weight, but starting doses are usually lower

Young, healthy patients with new-onset hypothyroidism may start at or near full replacement doses. Elderly patients and those with coronary artery disease typically start at low doses with gradual increases every 4-6 weeks to allow the cardiovascular system to adjust.

Timing and administration — critical for optimal absorption:

• Take at the same time every day — consistency is key
• Take on an empty stomach — food decreases absorption by 40%
• Best taken first thing in the morning, 30-60 minutes before breakfast
• Alternatively, take at bedtime at least 3-4 hours after the last meal (some studies suggest this may actually improve absorption)
• Take with water only — coffee, tea, and juice can affect absorption
• Separate from interfering substances by at least 4 hours:
  • Calcium supplements
  • Iron supplements
  • Antacids (especially aluminum/magnesium-containing)
  • Proton pump inhibitors (may reduce absorption)
  • Cholestyramine and other bile acid sequestrants
  • Sucralfate

Reaching the right dose (titration): Finding the optimal dose is an iterative process:

1. Start at an appropriate dose based on clinical factors
2. Check TSH 6-8 weeks after starting (it takes this long for levels to stabilize)
3. Adjust dose up or down based on TSH result and symptoms
4. Recheck TSH 6-8 weeks after each adjustment
5. Continue until TSH normalizes and symptoms resolve
6. Once stable, monitor TSH annually

The goal is to normalize TSH — typically bringing it into the reference range. Some patients feel best with TSH in the lower half of the normal range, while others do well anywhere within normal limits. Individual optimization may be needed.

Response to Treatment

Patients typically begin noticing improvement within 1-2 weeks of starting treatment, with more substantial improvement by 4-6 weeks. Full effect requires achieving stable hormone levels, which takes about 6 weeks due to T4’s long half-life.

Expected improvements include:

• Energy and fatigue: Usually among the first symptoms to improve; patients often report feeling “like themselves again”
• Mood and cognition: Improved mental clarity, better concentration, lifting of depression
• Cold intolerance: Gradual improvement in temperature tolerance
• Constipation: Usually resolves as gut motility normalizes
• Weight: Loss of the fluid weight and modest metabolic weight gain; typically 5-10 pounds over several months
• Skin and hair: Improvements take longer — weeks to months — as cellular turnover normalizes
• Cholesterol: LDL typically decreases significantly with treatment
• Menstrual function: Normalizes over 1-3 cycles

If symptoms don’t improve despite normal TSH, other causes should be investigated — hypothyroidism isn’t always the explanation for every symptom.

Liothyronine (T3) and Combination Therapy

Some practitioners use liothyronine (synthetic T3) either alone or in combination with levothyroxine. However, most guidelines and endocrinology organizations recommend levothyroxine monotherapy as standard treatment because:

• T4-to-T3 conversion occurs naturally and provides stable T3 levels
• T3 has a short half-life, causing fluctuating levels
• Clinical trials have not consistently shown benefit of combination therapy
• Some patients on T3 experience palpitations or other symptoms of excess

Combination therapy or T3 alone may be considered for selected patients who remain symptomatic despite normal TSH on levothyroxine, though this remains controversial.

Natural Desiccated Thyroid

Desiccated thyroid extract (derived from pig thyroid) contains both T4 and T3. Some patients prefer it, believing it more “natural.” However, the T4:T3 ratio differs from human physiology, and potency can vary between batches. Most professional guidelines recommend synthetic levothyroxine as first-line therapy due to consistent potency and extensive safety data.

Treatment of Subclinical Hypothyroidism

Whether to treat subclinical hypothyroidism (elevated TSH with normal Free T4) depends on several factors:

Favoring treatment:

• TSH persistently above 10
• Presence of symptoms attributable to thyroid
• Positive TPO antibodies (predicts progression)
• Pregnancy or planning pregnancy
• Goiter
• Dyslipidemia or cardiovascular risk factors

Monitoring without treatment may be appropriate for:

• Mildly elevated TSH (typically under 10)
• No symptoms
• Negative antibodies
• Elderly patients (benefit less clear, risk of overtreatment)

When not treating, TSH should be rechecked every 6-12 months to monitor for progression.

---

Living with Hypothyroidism

Lifelong Treatment

For most causes of hypothyroidism (Hashimoto’s, post-surgical, post-radioactive iodine), treatment is lifelong. The thyroid won’t recover, and stopping medication will cause hypothyroidism to return. However, with proper treatment, patients with hypothyroidism can live completely normal lives without limitations.

Monitoring

Once stable on levothyroxine, monitoring is straightforward:

• Annual TSH check to ensure dose remains appropriate
• TSH check 6-8 weeks after any dose adjustment
• TSH check if symptoms of over- or under-treatment develop
• TSH check if significant weight change occurs (dose may need adjustment)
• More frequent monitoring during pregnancy

Medication Adherence

Taking levothyroxine correctly ensures consistent effect:

• Take at the same time daily (consistency matters)
• Take on an empty stomach for best absorption
• Wait 30-60 minutes before eating or drinking (except water)
• Separate from calcium, iron supplements, and antacids by at least 4 hours
• Don’t skip doses; if missed, take as soon as remembered (but don’t double up)
• Store properly (away from heat and moisture)

Special Situations

Pregnancy: Thyroid hormone requirements increase by 25-50% during pregnancy. Women with hypothyroidism should have TSH checked as soon as pregnancy is confirmed, with dose increases as needed. Untreated or undertreated hypothyroidism during pregnancy risks fetal harm.

Surgery: Patients can generally continue levothyroxine through surgery. If unable to take oral medications for a prolonged period, intravenous thyroid hormone may be needed.

Aging: Thyroid hormone requirements may change with age. Elderly patients may need lower doses and are more susceptible to cardiac effects of overtreatment.

Other medications: Many medications interact with levothyroxine absorption or metabolism. Inform healthcare providers about thyroid medication when starting new drugs.

---

Prevention and Early Detection

The Case for Screening

Hypothyroidism is an ideal condition for screening because:

• It is common (affects 5% of adults)
• It causes significant morbidity if untreated
• Symptoms are nonspecific and often missed
• A simple, inexpensive blood test (TSH) detects it
• Treatment is highly effective, safe, and inexpensive
• Early detection prevents years of unnecessary symptoms and complications

Screening Recommendations

Professional organizations vary in their screening recommendations:

• American Thyroid Association recommends TSH screening beginning at age 35, then every 5 years
• AACE recommends screening older patients, especially women
• USPSTF found insufficient evidence to recommend for or against routine screening in asymptomatic adults (but doesn’t recommend against it)

Consensus supports testing individuals with symptoms, risk factors, or conditions associated with thyroid disease.

Prevention Limitations

Unlike some conditions, hypothyroidism generally cannot be “prevented” — Hashimoto’s thyroiditis (the main cause) is an autoimmune process influenced by genetics and factors not fully understood. However:

• Ensuring adequate iodine intake prevents iodine-deficiency hypothyroidism (rare in developed countries)
• Avoiding excessive iodine may reduce risk in susceptible individuals
• Early detection through screening prevents complications

---

Hypothyroidism and Related Conditions

Hypothyroidism often occurs alongside or affects other medical conditions. Understanding these relationships improves comprehensive care.

Cardiovascular Disease

The relationship between hypothyroidism and cardiovascular disease is significant and bidirectional:

• Dyslipidemia: Hypothyroidism raises LDL cholesterol by reducing LDL receptor expression. This accelerates atherosclerosis if untreated.
• Hypertension: Hypothyroidism often causes diastolic hypertension due to increased systemic vascular resistance.
• Cardiac effects: Reduced cardiac contractility, bradycardia, and in severe cases, pericardial effusion.
• Treatment consideration: In patients with known heart disease, thyroid hormone replacement should be started at low doses and increased gradually to avoid precipitating angina or arrhythmias.

Other Autoimmune Diseases

Hashimoto’s thyroiditis clusters with other autoimmune conditions, sharing common genetic susceptibility:

• Type 1 diabetes: Up to 30% of type 1 diabetics have thyroid antibodies; regular thyroid screening is recommended
• Celiac disease: 2-5% of celiac patients have autoimmune thyroid disease
• Rheumatoid arthritis: Increased prevalence of thyroid autoimmunity
• Vitiligo: Associated with autoimmune thyroid disease
• Pernicious anemia: Both involve autoimmunity; B12 deficiency should be considered in hypothyroid patients with macrocytic anemia
• Addison’s disease: Primary adrenal insufficiency; the combination of Addison’s and autoimmune thyroid disease is called Schmidt syndrome

Patients with one autoimmune condition should be aware of their increased risk for others and report relevant symptoms.

Mental Health

The relationship between hypothyroidism and mental health deserves special attention:

• Depression: Hypothyroidism commonly causes depressive symptoms. Some patients diagnosed with depression have undetected hypothyroidism. Thyroid testing should be considered in depressed patients, especially those not responding to antidepressants.
• Cognitive dysfunction: “Brain fog,” impaired concentration, and memory problems are common. These usually improve with treatment.
• Anxiety: Less common than depression but can occur.
• Bidirectional effect: While hypothyroidism causes mood symptoms, stress and depression may also affect thyroid function through the hypothalamic-pituitary axis.

Pregnancy and Fertility

Thyroid function is critical for reproductive health:

• Fertility: Hypothyroidism can cause anovulation and infertility. Normalizing thyroid function often restores fertility.
• Pregnancy requirements: Thyroid hormone requirements increase 25-50% during pregnancy. Women with hypothyroidism need early pregnancy testing and dose adjustment.
• Fetal development: Maternal thyroid hormone is essential for fetal brain development, especially in the first trimester before the fetal thyroid is functional. Untreated maternal hypothyroidism can impair fetal neurodevelopment.
• Postpartum thyroiditis: Autoimmune thyroid inflammation affecting 5-10% of women postpartum. May cause transient hyperthyroidism followed by hypothyroidism; some cases become permanent.

Obesity and Metabolic Syndrome

The relationship between hypothyroidism and weight is often misunderstood:

• Hypothyroidism causes modest weight gain (typically 5-10 pounds), primarily from fluid retention and decreased metabolic rate
• Severe obesity is rarely caused by hypothyroidism alone
• Obesity itself can mildly elevate TSH without true thyroid disease
• Weight loss after hypothyroidism treatment is usually modest — addressing obesity requires separate interventions

---

Key Takeaways

Hypothyroidism is a common, often undiagnosed condition that significantly impacts quality of life — yet it is one of the most treatable conditions in medicine. A simple blood test detects it, and a single daily pill treats it.

Key points to remember:

• Hypothyroidism affects approximately 5% of adults; up to 60% are undiagnosed
• Symptoms develop gradually and are often attributed to aging or stress
• Classic symptoms include fatigue, weight gain, cold intolerance, constipation, dry skin, and depression
• TSH is the screening test — elevated TSH indicates thyroid underfunction
• Hashimoto’s thyroiditis (autoimmune) is the most common cause
• Thyroid antibodies (TPO) confirm autoimmune etiology
• Untreated hypothyroidism causes dyslipidemia, cardiovascular disease, infertility, and other complications
• Treatment with levothyroxine is highly effective — symptoms resolve, and patients return to normal health
• Lifelong treatment is usually required, but monitoring is simple (annual TSH)
• Proper treatment allows completely normal life without limitations
• Screening high-risk individuals (women, elderly, family history) catches disease early

If you experience symptoms suggestive of hypothyroidism, ask your healthcare provider about TSH testing. Early diagnosis and treatment prevent years of unnecessary symptoms and protect long-term health.